We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Most hand-held injectors today are designed for standard drug containers, such as prefilled syringes or cartridges. The primary markets include treatments for chronic conditions such as diabetes and hormone deficiencies where repeat injections are necessary and are administered by the patient or a caregiver.
Typically, a device helps to simplify the patient injection experience, although many self-injections are still given with a basic prefilled syringe, potentially incorporating a needle-safety system or ergonomic accessories to improve an impaired patient’s ability to deliver an injection, particularly when it may be very viscous. Various sources suggest the market for prefilled syringes is getting close to three billion units per year, with a steady growth rate, although hand-held devices are used in only a portion of cases.
Growth continues in devices for insulin delivery, driven by continuing diagnosis and increased use of devices such as pens.
A key trend is an increased need for delivery systems capable of containing and delivering injectable doses of greater than 1mL, either in a single-dose rapid shot, or slowly over a longer period of time. This trend is driven by the challenges of next-generation biologics, including increased concentrations and higher viscosities. There is also a trend toward reduced dosing frequency, which may help improve patient comfort and compliance.
West offers a variety of self-injection technologies, including the SelfDoseTM, SmartDose® and ConfiDose® injector platform technologies. For more information click here.
SelfDoseTM, SmartDose® and ConfiDose® are trademarks or registered trademarks of West Pharmaceutical Services, Inc., or its affiliated companies, in the United States and other jurisdictions.
West seeks partners for its injector technology platforms. These platforms are intended to be used as an integrated system with drug filling and final assembly completed by the pharmaceutical/biotechnology company.
We are delighted to share that West has been honored at the Korea Bioprocessing Excellence Awards (KBEA) for the second year in a row. This year, we were recognized as the grand winner of the Best Bioprocessing Supplier Award: Fill-Finish.
With the help of the FDA’s expedited programs for approval, a new wave of high-value biologic drugs is on the rise in the pharma industry.1 These drugs require cryogenic storage (-80oC to -180oC) to maintain stability. This presents a new challenge: how to measure and demonstrate container closure integrity (CCI) of storage and delivery systems at such low temperatures.<br />
For many years, West has offered several ready-to-sterilize products that are qualified for a minimum 3-log Bacterial Endotoxin Reduction (BER). “Ready-to-sterilize” is known to West customers in Europe as “RS” quality. In other regions, such as South America or Asia, the ready-to-sterilize line of products includes our Superior Clean Product® (SCP) components and Enhanced Performance Products (EPP). These offerings reflect West’s commitment to quality components that support pharmaceuticals and biopharmaceuticals throughout the product lifecycle, while also fulfilling various regional market needs.
In the third and final installment of the <a href="https://www.youtube.com/watch?v=WrAvjl1C1iI"><span style="text-decoration: underline;">West On The Road</span></a> visit with our Clearwater, Florida facility, we dive a little bit deeper into the day-to-day processes and outside-the-box thinking that allows us to deliver packaging components and drug delivery systems of the highest quality.
In the world of injection molding, experience, expertise, and a passion for sharing knowledge can transform careers and shape the future of the industry. Ron Barr, a seasoned Principal Process Engineer at West, is a testament to this philosophy. With a remarkable journey that began back in 1991 when he joined the workforce at the age of 19, Ron's story is an inspiration to aspiring professionals in the field.
English
Chinese
